| 1 |
North American Regional Reanalysis
Fedor Mesinger, Geoff DiMego, Eugenia Kalnay et al. · Bulletin of the American Meteorological Society
Open access |
Mar 2006 |
3,526 |
| 2 |
Long-term Efficacy of Vedolizumab for Ulcerative Colitis
Edward V. Loftus, Jean‐Frédéric Colombel, Brian G. Feagan et al. · Journal of Crohn s and Colitis
Open access |
28 Sep 2016 |
222 |
| 3 |
Long-term Efficacy of Vedolizumab for Crohn’s Disease
Severine A.R.A. Vermeire, Edward V. Loftus, Jean‐Frédéric Colombel et al. · Journal of Crohn s and Colitis
Open access |
28 Sep 2016 |
216 |
| 4 |
A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease
Robert B. Burakoff, Charles F. Barish, Dennis Riff et al. · Inflammatory Bowel Diseases
|
27 Jun 2006 |
111 |
| 5 |
Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
Mark T. Osterman, Faten N. Aberra, Raymond Keith Cross et al. · Clinical Gastroenterology and Hepatology
Open access |
30 Apr 2014 |
93 |
| 6 |
An open-label evaluation of rifaximin in the treatment of active Crohn's disease
Ira Shafran, Lorin K. Johnson · Current Medical Research and Opinion
|
24 Jun 2005 |
68 |
| 7 |
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study
Claudia Peña Rossi, Stephen B. Hanauer, Ratko Tomašević et al. · BMC Gastroenterology
Open access |
20 Mar 2009 |
49 |
| 8 |
Utility of video capsule endoscopy for longitudinal monitoring of Crohn’s disease activity in the small bowel: a prospective study
GIL Y. MELMED, Marla C. Dubinsky, David T. Rubin et al. · Gastrointestinal Endoscopy
Open access |
4 Aug 2018 |
46 |
| 9 |
Adjunctive Antibiotic Therapy with Rifaximin May Help Reduce Crohn’s Disease Activity
Ira Shafran, Patricia Burgunder · Digestive Diseases and Sciences
|
28 Jan 2010 |
43 |
| 10 |
Presence of Infection by Mycobacterium avium subsp. paratuberculosis in the Blood of Patients with Crohn’s Disease and Control Subjects Shown by Multiple Laboratory Culture and Antibody Methods
J. Todd Kuenstner, Raghava Potula, Tim John Bull et al. · Microorganisms
Open access |
21 Dec 2020 |
26 |
| 11 |
Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin
Ira Shafran, Patricia Burgunder, David Wei et al. · Therapeutic Advances in Gastroenterology
Open access |
9 Jul 2015 |
26 |
| 12 |
Rifaximin for the Treatment of Newly Diagnosed Crohn's Disease: A Case Series
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Aug 2008 |
16 |
| 13 |
Efficacy and tolerability of rifaximin, a nonabsorbed oral antibiotic, in the treatment of active Crohn?s disease: results of an open-label study
Ira Shafran · The American Journal of Gastroenterology
|
Sep 2003 |
12 |
| 14 |
Visual Field Outcome Reporting in Neurosurgery: Lessons Learned from a Prospective, Multicenter Study of Transsphenoidal Pituitary Surgery
Michael A. Mooney, Angela M. Herro, Robert E. Fintelmann et al. · World Neurosurgery
|
22 Aug 2018 |
7 |
| 15 |
Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned
Anita Afzali, Matthew A. Ciorba, David A. Schwartz et al. · Inflammatory Bowel Diseases
|
19 Dec 2017 |
5 |
| 16 |
Evaluation of mucosal healing in Small Bowel Crohn’s disease treated with Certolizumab Pegol assessed by wireless capsule endoscopy
Ira Shafran, Patricia Burgunder, Renee DePanicis et al. · Clinical Case Reports and Reviews
Open access |
2016 |
3 |
| 17 |
Mobile and Web-Based Application for IBD Tracking
Ira Shafran, Patricia Burgunder, B Shamosh · Inflammatory Bowel Diseases
Open access |
Dec 2009 |
3 |
| 18 |
P-006 Evidence of Mucosal Healing in Patients with Crohnʼs Disease Treated with Open-Label Vedolizumab
Ira Shafran, R Laughlin, Patricia Burgunder · Inflammatory Bowel Diseases
|
5 Feb 2016 |
2 |
| 19 |
Potential pathogenic role of Mycobacterium avium subspecies paratuberculosis in Crohnʼs disease
Ira Shafran, Patricia Burgunder · Inflammatory Bowel Diseases
|
28 May 2008 |
2 |
| 20 |
Oral Serum-derived Bovine Immunoglobulin/Protein Isolate (SBI) in a Large, Single Center Experience Improves Symptomatology in Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome
Ira Shafran, Patricia Burgunder, Andrew Bertot · The American Journal of Gastroenterology
|
Oct 2014 |
1 |
| 21 |
Long-Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohnʼs Disease: 5-Year Results
Theadore Ptak, Ziad H Younes, Ira Shafran et al. · The American Journal of Gastroenterology
|
Oct 2015 |
1 |
| 22 |
Efficacy of Adalimumab Therapy in Patients with Crohnʼs Disease Who Were Unresponsive to or Intolerant of Infliximab: Six Years of Experience in a Single Gastroenterology Center
Ira Shafran, David J. Cangemi, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2010 |
1 |
| 23 |
Efficacy of adalimumab therapy in patients with Crohn's disease who were unresponsive to or intolerant of infliximab
Ira Shafran, David J. Cangemi, Patricia Burgunder · Inflammatory Bowel Diseases
|
2011 |
1 |
| 24 |
The Use of Wireless Capsule Endoscopy in Community Practice: An 11 Year Experience
Ira Shafran, Patricia Burgunder, Michael C. Kwa · Inflammatory Bowel Diseases
|
Dec 2012 |
1 |
| 25 |
Is monotherapy with an oral antibiotic useful in reducing Crohnʼs disease activity?
Ira Shafran · Inflammatory Bowel Diseases
|
May 2007 |
0 |
| 26 |
Comparative analysis of IBD serology
Patricia Burgunder, Ira Shafran, T Aplin · Inflammatory Bowel Diseases
|
Dec 2008 |
0 |
| 27 |
Retrospective Chart Review Study of Patients Receiving Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) for Nutritional Management of Irritable Bowel Syndrome with Diarrhea (IBS-D)
Larry I. Good, Leonard B. Weinstock, Ira Shafran et al. · The American Journal of Gastroenterology
|
Oct 2016 |
0 |
| 28 |
Rifaximin Monotherapy Was Effective in Patients with Newly Diagnosed Crohnʼs Disease
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Sep 2008 |
0 |
| 29 |
Rifaximin Maintenance Therapy for Crohnʼs Disease
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2009 |
0 |
| 30 |
Clinical Management of Lymphocytic Colitis With Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI)
Christine L. Frissora, Ira Shafran, Steven H. Silver et al. · The American Journal of Gastroenterology
|
Oct 2015 |
0 |
| 31 |
Open Label Investigation of Mucosal Healing in Patients with Small Bowel Crohnʼs Disease Treated with Certolizumab Pegol Assessed by Wireless Capsule Endoscopy
Ira Shafran, Patricia Burgunder, Alexander Max Fagenson · The American Journal of Gastroenterology
|
Oct 2011 |
0 |
| 32 |
Evaluation of Serology Results from Patients with Inflammatory Bowel Disease
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2009 |
0 |
| 33 |
Gender Differences in Infliximab Durability: A Single Center 13 Year Experience
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2011 |
0 |
| 34 |
A Single Centerʼs Experience with Capsule Endoscopy in 74 Patients with Crohnʼs Disease: Is It Safe?
Ira Shafran, Patricia Burgunder, Michael C. Kwa · The American Journal of Gastroenterology
|
Oct 2011 |
0 |
| 35 |
Comparison of Computed Tomographic Enterography with Standard Diagnostic Assessments for Detecting Active Crohnʼs Disease
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Sep 2008 |
0 |
| 36 |
Monitoring Patients with Ulcerative Colitis in Community-Based Practice to Improve Adherence
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Sep 2008 |
0 |
| 37 |
Monitoring Adherence and Outcomes in Patients with Inflammatory Bowel Disease
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2009 |
0 |
| 38 |
Efficacy of Certolizumab Pegol Therapy in Patients With Crohnʼs Disease
Ira Shafran, Sayel Al-Maani, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2010 |
0 |
| 39 |
Health Maintenance Strategies for the IBD Patient in Private Practice
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2010 |
0 |
| 40 |
Mesalamine Granules for the Treatment of Crohnʼs Colitis: A Case Study
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Oct 2010 |
0 |
| 41 |
Assessment of the Validity of Computed Tomographic Enterography for Diagnosing Active Crohnʼs Disease
Patricia Burgunder, Ira Shafran · The American Journal of Gastroenterology
|
Sep 2007 |
0 |
| 42 |
Rifaximin for the Treatment of Newly Diagnosed Crohnʼs Disease
Ira Shafran, Patricia Burgunder · The American Journal of Gastroenterology
|
Sep 2007 |
0 |
| 43 |
Economic and Clinical Impact of Serum-Derived Bovine Immunoglobulin / Protein Isolate (SBI) in the Management of Chronic Diarrhea in Inflammatory Bowel Disease (IBD)
Cortni Tyson, Ira Shafran, Raouf E. Hilal et al. · Value in Health
Open access |
Oct 2017 |
0 |
| 44 |
Certolizumab pegol as treatment for Crohnʼs disease in a community IBD practice
Ira Shafran, Patricia Burgunder, Faisal Fakih · Inflammatory Bowel Diseases
|
Dec 2011 |
0 |
| 45 |
Newly diagnosed Crohnʼs cisease: case series of rifaximin monotherapy
Ira Shafran, Patricia Burgunder · Inflammatory Bowel Diseases
|
2008 |
0 |
| 46 |
Long-term Rifaximin Treatment for Newly Diagnosed Crohnʼs Disease
Ira Shafran, Patricia Burgunder · Inflammatory Bowel Diseases
Open access |
Dec 2009 |
0 |
| 47 |
Adalimumab Therapy for Patients With Crohnʼs Disease Who Are Unresponsive to or Intolerant of Infliximab
Ira Shafran, Patricia Burgunder, A Fakih · Inflammatory Bowel Diseases
|
Dec 2009 |
0 |
| 48 |
Does Combination Therapy using Rifaximin with Adalimumab improve Crohnʼs Disease activity and Mucosal Healing? A Case Series
Ira Shafran, Patricia Burgunder · Inflammatory Bowel Diseases
|
Dec 2009 |
0 |